Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia
Anuradha Kirtonia, Gouri Pandya, Gautam Sethi, et al.
Journal of Molecular Medicine (2020) Vol. 98, Iss. 8, pp. 1069-1091
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
Manoj Garg, Muthu K. Shanmugam, Vipul Bhardwaj, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1291-1336
Closed Access | Times Cited: 119
Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers
Yi‐Ting Chen, Jieling Ning, Wenjie Cao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 92
Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer
Milad Ashrafizadeh, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, et al.
Bioengineering (2020) Vol. 7, Iss. 3, pp. 91-91
Open Access | Times Cited: 85
Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers
Milad Ashrafizadeh, Ali Zarrabi, Maryam Hashemipour, et al.
Pharmacological Research (2020) Vol. 160, pp. 105199-105199
Closed Access | Times Cited: 76
Xanthohumol from Hop: Hope for cancer prevention and treatment
Sosmitha Girisa, Queen Saikia, Devivasha Bordoloi, et al.
IUBMB Life (2021) Vol. 73, Iss. 8, pp. 1016-1044
Open Access | Times Cited: 63
Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases
Anjana Sajeev, Mangala Hegde, Sosmitha Girisa, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1185-1185
Open Access | Times Cited: 42
Adverse effects in hematologic malignancies treated with chimeric antigen receptor (CAR) T cell therapy: a systematic review and Meta-analysis
Wenjing Luo, Chenggong Li, Yinqiang Zhang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 40
Long noncoding RNAs: A novel insight in the leukemogenesis and drug resistance in acute myeloid leukemia
Anuradha Kirtonia, Milad Ashrafizadeh, Ali Zarrabi, et al.
Journal of Cellular Physiology (2021) Vol. 237, Iss. 1, pp. 450-465
Closed Access | Times Cited: 47
An overview of the pharmacological activities of scopoletin against different chronic diseases
Parama Dey, Sosmitha Girisa, Elina Khatoon, et al.
Pharmacological Research (2022) Vol. 179, pp. 106202-106202
Closed Access | Times Cited: 34
Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics
Aviral Kumar, Sosmitha Girisa, Mohammed S. Alqahtani, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 810-810
Open Access | Times Cited: 20
Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review
Elika Verma, Aviral Kumar, Uzini Devi Daimary, et al.
Journal of Functional Foods (2021) Vol. 86, pp. 104660-104660
Open Access | Times Cited: 38
UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation
Li Wang, Shuqin Zhao, Yongling Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
“FLipping” the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors
Tristan Knight, Holly Edwards, Soheil Meshinchi, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3398-3398
Open Access | Times Cited: 20
Resveratrol and Its Role in the Management of B-Cell Malignancies—A Recent Update
Dhruv Gupta, Vaishnavi Gadi, Ginpreet Kaur, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 221-221
Open Access | Times Cited: 10
A phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis
Jingjing Yang, Qingyang Liu, Xiawei Zhang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114268-114268
Closed Access
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia
Arnaud Métois, Marie-Ève Bordeleau, Louis Thérêt, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Galectin-1: An important regulator in myeloid differentiation and acute myeloid leukemia as well as a promising prognostic indicator and therapeutic target
Lulu Liu, Panpan Cheng, Junjie Cui, et al.
International Immunopharmacology (2025) Vol. 158, pp. 114835-114835
Closed Access
Venom peptides in cancer therapy: An updated review on cellular and molecular aspects
Sepideh Mirzaei, Hojjat Samareh Fekri, Farid Hashemi, et al.
Pharmacological Research (2020) Vol. 164, pp. 105327-105327
Closed Access | Times Cited: 27
p21-Activated kinases as promising therapeutic targets in hematological malignancies
Andrew Wu, Xiaoyan Jiang
Leukemia (2021) Vol. 36, Iss. 2, pp. 315-326
Closed Access | Times Cited: 21
Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases
Uzini Devi Daimary, Sosmitha Girisa, Parama Dey, et al.
Journal of Biochemical and Molecular Toxicology (2021) Vol. 36, Iss. 2
Closed Access | Times Cited: 21
Current stage of preclinical and clinical development of guggulsterone in cancers: Challenges and promises
Shumaila Ijaz, Javed Iqbal, Bilal Haider Abbasi, et al.
Cell Biology International (2023) Vol. 48, Iss. 2, pp. 128-142
Closed Access | Times Cited: 9
HMGB1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target
Lulu Liu, Jingjing Zhang, Xianning Zhang, et al.
Journal of Molecular Medicine (2020) Vol. 99, Iss. 1, pp. 107-118
Open Access | Times Cited: 22
Molecular and genomic landscapes in secondary & therapy related acute myeloid leukemia.
Harsh Goel, Ekta Rahul, Ishan Gupta, et al.
PubMed (2021) Vol. 11, Iss. 5, pp. 472-497
Closed Access | Times Cited: 18
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 5, pp. 512-534
Closed Access | Times Cited: 2
Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells
Abdolreza Osali, Mina Zhiani, Mahnaz Ghaebi, et al.
Pharmacological Research (2020) Vol. 161, pp. 105094-105094
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top